NCT04341454View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

PHASE3CompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

June 2, 2020

Primary Completion Date

August 4, 2021

Study Completion Date

September 16, 2021

Conditions
Acute GastritisChronic Gastritis
Interventions
DRUG

DWP14012 X mg

DWP14012 X mg, tablet, orally, once daily for 2 weeks

DRUG

DWP14012 X mg placebo

DWP14012 X mg placebo-matching tablet, orally, once daily for 2 weeks

DRUG

DWP14012 Y mg

DWP14012 Y mg, tablet, orally, twice daily for 2 weeks

DRUG

DWP14012 Y mg placebo

DWP14012 Y mg placebo-matching tablet, orally, twice daily for 2 weeks

Trial Locations (1)

Unknown

Hanyang University Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT04341454 - Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis | Biotech Hunter | Biotech Hunter